DGAP-News: Joh. Berenberg, Gossler & Co. KG / Key word(s): Miscellaneous Correction of a release from 28.09.2016, 20:53 CET/CEST - Notification of Stabilization Measures in accordance with Article 5 (4) and (6) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ('Market Abuse Regulation') 29.09.2016 / 09:24 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of Stabilization Measures in accordance with Article 5 (4) and (6) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ('Market Abuse Regulation') NOT FOR DISTRIBUTION OR PUBLICATION IN THE UNITED STATES, CANADA, AUSTRALIA, OR JAPAN. Notification of Stabilization Measures in accordance with Article 5 (4) and (6) of Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse ('Market Abuse Regulation') and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and in accordance with Article 6 (1) of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016. Joh. Berenberg, Gossler & Co. KG ('Berenberg' or the 'Stabilization Manager'), in connection with the initial public offering of Shop Apotheke Europe N.V., Venlo, the Netherlands (the 'Company'), acts as Stabilization Manager and will have the right, in the time period beginning and including 13 Oktober 2016 through and including 12 November 2016 (the 'Stabilization Period'), with regard to the Company's shares, which are expected to be admitted to trading on the regulated market of the Frankfurt Stock Exchange (Prime Standard) (International Securities Identification Number (ISIN: NL0012044747; German Securities Code (WKN): A2AR94) on 13 October 2016, in the scope admissible under Article 5 (4) of the Market Abuse Regulation, to make Over-Allotments or carry out Stabilization Measures on behalf and for the account of individual underwriters (the 'Stabilization Measures'). Stabilization Measures are intended to provide support for the stock exchange or market price of the Company's securities during the Stabilization Period if the securities come under selling pressure, thus alleviating sales pressure generated by short-term investors and maintaining an orderly market in those securities. Stabilization Measures may cause the stock exchange or market price of the shares to be higher than it would otherwise have been. In addition, the stock exchange or market price may temporarily be at a level that is not sustainable. In addition, stabilization activities may give false or misleading signals regarding the supply of the securities. The Stabilization Manager may carry out Stabilization Measures at the regulated market of the Frankfurt Stock Exchange. The Stabilization Manager is not required to carry out Stabilization Measures. Therefore, no assurance can be provided that Stabilization Measures will be carried out. As a result, Stabilization Measures may not necessarily be carried out and any Stabilization Measures may cease at any time without advance notice. In any Stabilization Measures that may be carried out, and to the extent permitted by law, up to 535,714 additional shares may be alloted to investors as part of the offering in addition to the initial offer of shares in the Company (the 'Over-Allotment'). In connection with a potential Over-Allotment, the Stabilization Manager, acting on behalf and for the account of the underwriters, was provided with up to 535,714 shares from the holdings of the selling shareholders by way of a securities loan granted free of charge, and this number of shares amounts up to 15% of the shares to be issued by the Company pursuant to the offering capital increase. In this context, with the sole purpose of covering potential Over- Allotments, the selling shareholders have granted the Stabilization Manager on behalf and for the account of the underwriters an option to acquire up to 535,714 Over-Allotment Shares from the holdings of the selling shareholders (the 'Over-Allotment Shares') at the offer price less agreed commissions, thus satisfying the retransfer obligation under the securities loan (the 'Greenshoe Option'). The Stabilization Manager may exercise the Greenshoe Option on behalf and for the account of the underwriters. The Greenshoe Option will expire 30 calendar days after stock exchange trading in the shares commences and may only be exercised to the extent shares have been placed by way of Over-Allotment. During the Stabilization Period, the Stabilization Manager ensures adequate public disclosure of the details of any Stabilization Measures by the end of the seventh day of trading following the date on which Stabilization Measures were carried out. Within one week of the end of the Stabilization Period, adequate public disclosure of the following information will be made: whether or not Stabilization Measures were carried out; the dates on which any price Stabilization Measures started and ended; the date on which Stabilization Measures last occurred; the price range within which Stabilization Measures were carried out (for each date of a Stabilization Measure); and the trading venues on which Stabilization Measures (if any) were carried out. Joh. Berenberg, Gossler & Co. KG Disclaimer This communication is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan. This communication does not constitute or form part of an offer of securities for sale or solicitation of an offer to purchase securities in the United States, Canada, Australia, Japan or in any other jurisdiction in which such offer may be restricted. The securities referred to in this communication have not been, and will not be, registered under the US Securities Act of 1933, as amended (the 'Securities Act'), and may not be offered or sold in the United States, except on the basis of an applicable exemption from the registration requirements or in a transaction not subject to the registration requirements of the Securities Act. There will be no public offering of securities in the United States. In the United Kingdom, this communication is directed only at persons who: (i) are qualified investors within the meaning of the Financial Services and Markets Act 2000 (as amended) and any relevant implementing measures and/or (ii) are outside the United Kingdom or (iii) have professional experience in matters relating to investments and fall within the definition of 'investment professionals' contained in article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the 'Order') or are persons falling within article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order, or fall within another exemption to the Order (all such persons referred to in (i) to (iii) above together being referred to as 'Relevant Persons'). Any person who is not a Relevant Person must not act or rely on this communication or any of its contents. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. --------------------------------------------------------------------------- 29.09.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- 506955 29.09.2016
DGAP-News: Correction of a release from 28.09.2016, 20:53
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Growth Outlook for the Packaging Robots Market to 2032
The Expanding Landscape of Packaging Robots The Packaging Robots Market is on an exciting trajectory, projected to soar from an estimated USD 6.02 billion in 2023 to an impressive USD 16.67 billion by 2032. This remarkable growth is fueled by continuous technological advancements and the ever-increasing demand for automation, as businesses strive for greater efficiency in...
Continue Reading
Analyzing the Short Interest Trends for AutoZone Inc
Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...
Continue Reading
Join the Fight: Investors Urged to Act Against Flywire's Missteps
Critical Insights into Flywire Corporation's Recent Challenges In light of recent events, investors in Flywire Corporation (NASDAQ: FLYW) are presented with a pivotal opportunity to address potential securities fraud claims. Allegations suggest that the company might have communicated misleading business information to the public, raising concerns among its shareholders....
Continue Reading
LEPAS L8: A Game-Changer for Electric Vehicle Enthusiasts
LEPAS L8: Redefining the Future of NEVs The innovative leap forward in the world of electric vehicles comes with Chery Group's brand new energy vehicle (NEV) brand, LEPAS, and its latest offering, the L8 model. The introduction of the L8 marks a significant milestone for Chery as it establishes a new standard in driving sophistication. This model is poised to make waves...
Continue Reading
Integra LifeSciences Launches Pediatric Registry for AERA System
Integra LifeSciences Initiates Pediatric AERA Registry Integra LifeSciences Holding Corporation (Nasdaq: IART), a premier global leader in medical technology, has taken a significant step forward by enrolling the first patient in the Acclarent AERA Pediatric Registry. This multi-center observational registry aims to evaluate the real-world applications of the AERA...
Continue Reading